Keypharm SA
18.0 FTEThe score of Keypharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +30 % Equity +35 % Total assets +26 % Headcount (avg FTE) +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Keypharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €14.9m | ||||
| Net result | €1.56m | ||||
| Equity | €5.20m | ||||
| Cash | 57,871 € | ||||
| EBITDA | €2.29m | ||||
| Total assets | €9.49m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 26 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Keypharm's financial analysis
- Solvency54.8%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Keypharm
Keypharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0883.397.311
- VAT number
- BE0883397311
- Peppol
- Not found on Peppol as of 09 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 08 Sep 2006
- Registered office
- 8020 Oostkamp
- Size
- Small · 18.0 FTE
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Keypharm (SA) has been based in Oostkamp since 2006, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €14.9m, a net profit of €1.56m and equity of €5.20m. With 18.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 54.8%, above the median of its sector (46.0%).
Companies similar to Keypharm
Companies in the same business, of comparable size and area, outside its group.
- Ecuphar Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet €164.1m
- Magis-Pharma Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €12.5m
- PI Pharma Wholesale of pharmaceutical and medical goods Sint-Pieters-Leeuw · balance sheet €13.2m
- Fagron Belgium Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €7.86m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- Zambon Wholesale of pharmaceutical and medical goods Jette · balance sheet €7.67m
- KRKA Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €9.03m
- Teleflex Medical Wholesale of pharmaceutical and medical goods Brussels · balance sheet €8.88m
Frequently asked questions about Keypharm
What is the revenue of Keypharm?
According to the 2025 annual accounts filed with the NBB, the revenue of Keypharm amounts to 14,877,926 €.
What is the VAT number of Keypharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0883397311 for Keypharm, if the company is VAT-registered. Its company number (CBE) is 0883.397.311.
Where is the registered office of Keypharm?
According to the CBE register, the registered office of Keypharm is in 8020 Oostkamp.
What is the equity of Keypharm?
At the close of the 2025 financial year, the equity of Keypharm amounts to 5,202,102 €, a solvency of 54.8% of total assets.
How many people work at Keypharm?
18.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Keypharm?
The register lists 8 active mandates at Keypharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Keypharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →